Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 355 across all filing types
Latest filing 2020-03-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '큐로컴'. It outlines the date, location, and agenda items (such as approval of financial statements, appointment of auditors, and director remuneration). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2020-03-04 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Curocom Co., Ltd. It contains the meeting agenda, date, location, and detailed management reference materials (경영참고사항) including board activity, major shareholder transactions, and business overviews. This document is a standard proxy statement/notice sent to shareholders to inform them of the upcoming meeting and provide necessary information for voting. In the context of the provided filing categories, this aligns with 'Proxy Solicitation & Information Statement'.
2020-03-04 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) filed by Curocom Co., Ltd. for its 23rd Annual General Meeting. It contains details about the solicitor, the purpose of the solicitation (securing a quorum for the AGM), the date and location of the meeting, and specific agenda items (approval of financial statements). It also includes detailed business reports (industry status, growth, and economic trends) which are typical components of a proxy statement/information statement provided to shareholders to request their votes. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2020-03-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and special relationships of major shareholders (Curo Holdings and its affiliates) in the issuer (Curocom). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-02-28 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2020-02-21 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) from a South Korean company, Curocom, detailing a decision for a third-party capital increase (유상증자결정). This type of filing is a mandatory regulatory disclosure regarding changes in capital structure and share issuance. In the context of the provided categories, this falls under 'Share Issue/Capital Change' (SHA) as it specifically details the issuance of new shares, the purpose of the capital raise, and the third-party allocation details.
2020-02-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.